- Home
- QURE vs ALTI Comparison
QURE vs ALTI Comparison
Compare QURE & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- ALTI
- Stock Information
- Founded
- QURE 1998
- ALTI 2020
- Country
- QURE Netherlands
- ALTI United States
- Employees
- QURE N/A
- ALTI N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- ALTI Investment Managers
- Sector
- QURE Health Care
- ALTI Finance
- Exchange
- QURE Nasdaq
- ALTI Nasdaq
- Market Cap
- QURE 432.6M
- ALTI 349.0M
- IPO Year
- QURE 2007
- ALTI N/A
- Fundamental
- Price
- QURE $5.85
- ALTI $4.29
- Analyst Decision
- QURE Buy
- ALTI Strong Buy
- Analyst Count
- QURE 6
- ALTI 1
- Target Price
- QURE $17.00
- ALTI $9.00
- AVG Volume (30 Days)
- QURE 792.5K
- ALTI 182.4K
- Earning Date
- QURE 11-05-2024
- ALTI 11-08-2024
- Dividend Yield
- QURE N/A
- ALTI N/A
- EPS Growth
- QURE N/A
- ALTI N/A
- EPS
- QURE N/A
- ALTI N/A
- Revenue
- QURE $28,587,000.00
- ALTI $246,970,000.00
- Revenue This Year
- QURE $157.96
- ALTI N/A
- Revenue Next Year
- QURE N/A
- ALTI $16.69
- P/E Ratio
- QURE N/A
- ALTI N/A
- Revenue Growth
- QURE N/A
- ALTI 39.57
- 52 Week Low
- QURE $3.73
- ALTI $3.47
- 52 Week High
- QURE $11.35
- ALTI $9.22
- Technical
- Relative Strength Index (RSI)
- QURE 43.86
- ALTI 50.28
- Support Level
- QURE $5.50
- ALTI $3.67
- Resistance Level
- QURE $7.96
- ALTI $4.48
- Average True Range (ATR)
- QURE 0.59
- ALTI 0.28
- MACD
- QURE -0.16
- ALTI -0.07
- Stochastic Oscillator
- QURE 18.97
- ALTI 46.62
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments that includes Wealth Management and Strategic Alternatives. Wealth Management includes providing holistic solutions for their wealth management clients through their comprehensive range of wealth management services, including investment management and advisory services. Strategic Alternatives segment, it assists their investors with alternative investments and co-investments by providing access to highly differentiated opportunities in these areas.